Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders
Prof Dr Regina Fluhrer from Biomedical Center (BMC), Ludwig Maximilians University of Munich (LMU) & German Center for Neurodegenerative Diseases (DZNE) shares her expertise on the field of intramembrane proteases, focussing on regulation of cellular pathways
The work of the EU Joint Programme – Neurodegenerative Disease Research (JPND) which aims to tackle the challenge of these diseases, in particular, Alzheimer’s, is discussed here
Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?
Dr Yves Joanette, Scientific Director at the CIHR Institute of Aging argues for a balanced approach when it comes to their collaboration-based approach to face the challenge of dementia
The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.
Tamas Fulop from Université de Sherbrooke’s Research Center on Aging, explains precisely why infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease (AD)
Scientists from the National Institutes of Health (NIH) compared the genetic clocks of normal and mutant flies to understand the link between neurodegenerative disorders such as Alzheimer’s disease and the ageing process
Svein Olaf Olsen and Maiken Arnesen from the European Huntington Association reveal their thoughts on a recent and significant breakthrough concerning Huntington’s Disease (HD)...
UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's
Neurodegenerative diseases are...
The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s
My PD Journey is a multi-stakeholder...
